Delphine Courmier | Health Economics Director, Biosimilars
Amgen Inc

Delphine Courmier, Health Economics Director, Biosimilars, Amgen Inc

Dr Delphine Courmier is a Health Economics Director at Amgen with the responsibility of the biosimilar portfolio in the HTA Center of Excellence as well as Global Health Economics for the oncology biosimilars.

Delphine joins from Baxter where she was Global Market Access lead for 2 hospital products global Franchises. Prior to this role, she worked in Market Access and Health Economics both in consulting and industry in pharma (Novartis, Ipsen) and medical devices (J&J) since 2010. Her earlier career was in R&D in material design for various industries. Her last R&D project before switching to Market Access was to develop semiconductor-based sensors for airborne pathogens.

Delphine has an MBA from London Business School, a Ph.D. in Computational Chemistry from the University of Ottawa, Canada, an MSc. and BSc. in Chemistry from Université Pierre et Marie Curie Paris 6, France and a European Market Access University Diploma from Université Claude Bernard Lyon 1, France.

Appearances:



Biosimilars Day 1 - Monday 29th October 2018 @ 17:50

Panel discussion: How can we best converge strategies and regulatory environments to market a biosimilar in an emerging market country in the future?

Biosimilars Day 2 - Tuesday 30th October 2018 @ 11:25

Biosimilars: the vastly evolving HTA landscape

  • Biosimilar national HTA archetypes
  • Integrating Biosimilars in the therapeutic strategy:
  • Reimbursement in extrapolated indications, reimbursement of a biosimilar when the originator was not cost-effective, pharmacy substitution
  • Hospital-Based HTA for Biosimilars: How do providers and hospitals decide which biosimilar to list on their formulary?
last published: 26/Sep/18 12:15 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

 

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates